Showing all 14 results
Acyclovir Dispersible Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated, Dispersible Tablets (often flavored/sweetened for palatability), packed in moisture-resistant blister strips.
Active Ingredient Strength Primary Clinical Use Acyclovir USP/BP/Ph.Eur. 200 mg HSV-1 & HSV-2 (Genital/Labial Herpes) Treatment Acyclovir USP/BP/Ph.Eur. 400 mg Recurrent HSV Suppression / Chronic Prophylaxis Acyclovir USP/BP/Ph.Eur. 800 mg Varicella (Chickenpox) & Herpes Zoster (Shingles) Excipients Crospovidone / Aspartame / Flavoring Agents Superdisintegrant / Sweetener / Taste-Masking Adefovir Dipivoxil Tablets
FreeProduct Composition & Strengths
We supply this therapeutic in the globally accepted standard therapeutic strength optimized for adult daily maintenance therapy.
Active Ingredient Standard Strength Primary Clinical Target Adefovir Dipivoxil IP / BP / USP 10 mg The Polymerase Blocker: Daily oral dose to suppress chronic Hepatitis B viral loads. Excipients Pharma Grade The Matrix: High-stability lactose/microcrystalline cellulose binders. Entacavir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the potent antiviral API.
Active Ingredient Strength Primary Clinical Function Entecavir (as Monohydrate) USP/Ph.Eur. 0.5 mg The Global Nucleoside-Naive Standard: The definitive ultra-micro-dose utilized for the daily, lifelong suppression of HBV in patients who have never received prior antiviral therapy. Entecavir (as Monohydrate) USP/Ph.Eur. 1.0 mg The Refractory & Cirrhosis Standard: Double-strength therapeutic payload utilized specifically for patients with Lamivudine-resistant HBV viremia or those suffering from decompensated liver cirrhosis. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Crospovidone / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the microscopic 0.5mg payload is flawlessly distributed throughout the tablet matrix, preventing toxic “hot spots” or sub-therapeutic failures) *Pack Sizes: 3×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic hepatology dispensing regimens).
Favipiravir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pyrazinecarboxamide derivative.
Active Ingredient Strength Primary Clinical Function Favipiravir USP/Ph.Eur. 200 mg The Global Outbreak Standard: Base therapeutic unit utilized for standard, highly flexible titration during acute viral hemorrhagic fevers or novel influenza outbreaks. Favipiravir USP/Ph.Eur. 400 mg / 800 mg The Pill-Burden Reduction Macrodose: Massive therapeutic payload engineered specifically to solve the severe “Day 1 Loading Dose” compliance nightmare (allowing a patient to take two 800mg pills instead of eight 200mg pills). Excipients Microcrystalline Cellulose / Crospovidone / Povidone K-30 / Colloidal Silicon Dioxide / Sodium Stearyl Fumarate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Glidant / Lubricant (Engineered specifically utilizing advanced high-shear wet granulation to compress massive, bulky API doses into smooth, easily swallowable tablets, finished with a heavy film-coat to lock out tropical humidity) *Pack Sizes: 10×10 Alu-Alu Blisters or Complete Therapy “Outbreak Kits” (e.g., 34-tablet or 40-tablet regimen boxes).
Ganciclovir Capsules
FreeGanciclovir capsules (commonly found in 250 mg and 500 mg strengths) contain the active antiviral drug ganciclovir, a synthetic guanine derivative used to treat and prevent cytomegalovirus (CMV) infections
Ganciclovir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient and protect healthcare handlers from cytotoxic exposure.
Active Ingredient Strength Primary Clinical Function Ganciclovir USP/Ph.Eur. 250 mg Renal Titration Standard: Base therapeutic unit utilized for strict, calculated dose reductions in transplant patients suffering from severe renal impairment (low creatinine clearance). Ganciclovir USP/Ph.Eur. 500 mg Global Maintenance Standard: High-efficacy adult maintenance dose utilized for daily, long-term suppression of CMV retinitis to prevent viral relapse. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically to lock the highly mutagenic and carcinogenic API safely inside the tablet, completely preventing caregiver and pharmacist exposure to toxic airborne dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 84 (Optimized specifically for strict, high-volume chronic infectious disease dispensing regimens).
Lamivudine Tablets
FreeProduct Composition & Available Portfolio strengths
We manufacture Lamivudine across the precise compendial strengths mandated to manage either targeted chronic hepatic monotherapy or high-potency systemic combination antiretroviral protocols.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lamivudine USP / BP / IP 100 mg Oral Solid Film-Coated Tablet Chronic Hepatitis B (HBV): Low-dose configuration optimized for standalone daily suppression of active hepatic viral replication. Lamivudine USP / BP / IP 150 mg Oral Solid Film-Coated Tablet Standard Antiretroviral (HIV): Baseline strength designed for twice-daily co-administration or integration into standard multi-drug ARV regimens. Lamivudine USP / BP / IP 300 mg Oral High-Potency Solid Tablet High-Compliance Antiretroviral (HIV): Standard adult once-daily high-dose format engineered to optimize long-term patient compliance. Nelfinavir Tablet
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. Due to the high dose required for therapeutic efficacy, we ensure the tablet is engineered for ease of swallowing without compromising the structural integrity of the high-API load.
Active Ingredient Strength (Standard) Therapeutic Role Nelfinavir Mesylate USP/BP 250 mg Standard Adult / Pediatric Dose Nelfinavir Mesylate USP/BP 625 mg High-Strength Adult Maintenance Excipients Q.S. Calcium Silicate / Crospovidone Disintegrant & Stabilizer Oseltamivir Tablet
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Hard Gelatin Capsule, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the hygroscopic phosphate salt.
Active Ingredient Strength Primary Clinical Function Oseltamivir Phosphate USP/Ph.Eur. 75 mg (Equivalent to Oseltamivir free base) Global Standard: Target adult dose for rapid treatment and prophylaxis of Influenza A/B. Excipients Pregelatinized Starch / Croscarmellose Sodium / Povidone / Sodium Stearyl Fumarate Diluent / Superdisintegrant (Engineered for immediate gastric capsule rupture and rapid systemic absorption) *Pack Sizes: 1×10 Blisters (Optimized perfectly for the standard 5-day acute treatment regimen of two capsules daily).
Ribavirin Capsules
FreeRibavirin capsules are antiviral medications typically used in combination with other drugs (like interferon or sofosbuvir) to treat chronic Hepatitis C. They are most commonly available in a 200 mg strength, though 100 mg versions also exist.
Ribavirin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the stability of the active nucleoside analog and protect handlers from exposure.
Active Ingredient Strength Primary Clinical Function Ribavirin USP/Ph.Eur. 200 mg Global Clinical Standard: Base titration unit for precise, weight-based antiviral dosing. Ribavirin USP/Ph.Eur. 400 mg High-dose unit to drastically improve pill-burden compliance in heavy patients. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone / Magnesium Stearate Diluent / Superdisintegrant / Binder (Engineered for immediate gastric dissolution and rapid systemic absorption) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for high-dose, weight-based daily regimens requiring 4 to 6 tablets per day).
Tenofovir Tablets
FreeAbivir
Tenofovir Disoproxil Fumarate Tablet 300 mg
Each Film Coated Tablet Contains:
Tenofovir Disoproxil Fumarate 300 mgUsage: – help control HIV infection
Category: – HIV Anti viral drugs
Therapeutic category: – Antiviral, Anti HIV
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Valganciclovir Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles for chronic dispensing regimens.
Active Ingredient Strength Primary Clinical Use Valganciclovir Hydrochloride USP/Ph.Eur. 450 mg (Equivalent to Valganciclovir free base) Standard Adult Dose for CMV retinitis induction/maintenance and transplant prophylaxis. Excipients Povidone / Crospovidone / Microcrystalline Cellulose / Stearic Acid Binder / Superdisintegrant / Diluent (Ensures rapid gastric dispersion and prodrug integrity) Zidovudine Tablet
FreeProduct Composition & Strength
We supply this product in standardized strengths optimized for both monotherapy (in specific PMTCT cases) and combination therapy (HAART).
Active Ingredient Strength Primary Clinical Target Zidovudine IP/BP/USP 300 mg The Foundation: Standard dose for adult HIV management. Excipients Pharma Grade The Matrix: Ensures shelf-life stability and rapid absorption.
